MedPath

A Clinical Trial on Effectiveness and Safety of Hydrogen Generator to Treat Dyspnea for the Patients With Tracheal Stenosis: A Randomized, Double-blind and Single-center Clinical Study

Not Applicable
Conditions
Tracheal Stenosis
Interventions
Device: Hydrogen generator treatment
Device: Oxygen-making machine treatment
Registration Number
NCT02961387
Lead Sponsor
Guangzhou Institute of Respiratory Disease
Brief Summary

Investigators aim to study the effectiveness and safety of inhaling hydrogen-oxygen which produced by a hydrogen generator with nebulizer to decreases inspiratory effort for the patients with tracheal stenosis.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  1. Aged from 18 to 65;
  2. Diagnosed moderate/severe tracheal stenosis by chest CT and/or bronchoscopy;
  3. Difficulty breathing symptoms
  4. Agree to participate in this trial and sign the informed consent form.
Exclusion Criteria
  1. Those who were suffered from respiratory failure or more severe caused by dyspnea;
  2. Combined other serious systemic diseases (severe arrhythmia, acute myocardial ischemia, uncontrollable hypertension crisis, active gastric ulcer, uncontrolled diabetes, renal failure, blood system diseases or coagulation dysfunction);
  3. Those who were suffered from severe mental illness or could not take care of themselves;
  4. Pregnant or lactating women;
  5. Those who could not understand the trial procedures and correctly the trial equipment;
  6. Those who participated in other clinical trials in the first 3 months before the screening date.

Quit criteria

  1. The subjects requiring emergency intubation or other intervention or surgical treatment due to worsened tracheal stenosis;
  2. Subjects who had severe adverse events during treatment;
  3. Subjects who did not want to continue to participate in the trial;
  4. The subjects who were necessarily terminated for the trial by the investigators.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Hydrogen generator treatmentHydrogen generator treatmentInhalation of hydrogen-oxygen mixed gas.
Oxygen-making machine treatmentHydrogen generator treatmentInhalation of oxygen.
Hydrogen generator treatmentOxygen-making machine treatmentInhalation of hydrogen-oxygen mixed gas.
Oxygen-making machine treatmentOxygen-making machine treatmentInhalation of oxygen.
Primary Outcome Measures
NameTimeMethod
Change in sRMSdi/para/sc, RMSdi, Pdi& MIP from baseline after inhalation by bench study.Baseline, 10min, 20min, 30min, 40min, 50min, 90min and 150min

sRMSdi/para/sc: root-mean-square of diaphragm/parasternal/sternocleidomastoid surface electromyography; RMSdi: root-mean-square of diaphragm electromyography; Pdi: Transdiaphragmatic pressure; MIP:maximal inspiratory pressure.

Secondary Outcome Measures
NameTimeMethod
Grades of airway stenosis by bronchoscopybaseline
Change in Borg score for dyspnea after inhalation.Baseline, 10min, 20min, 30min, 40min, 50min, 90min and 150min
Change in symptom of dyspnea from baseline after inhalation.Baseline, 10min, 20min, 30min, 40min, 50min, 90min and 150min

Changes in comfort with each gas mixture were evaluated by a simple questionnaire

Change in signs(BR, HR, BP, el) from baseline after inhalationBaseline, 10min, 20min, 30min, 40min, 50min, 90min and 150min

Change in signs include breath rate, heart rate, blood pressure,Three Depression Sign and so on.

Change in PaO2, PaCO2, PH& HCO3- after inhalationBaseline and 150min

Change in Arterial blood gases.

FEV1 & FVCBaseline

Forced expiratory volume in one second \& Forced vital capacity.

Change in impulse oscillometry variables(R5,R20,X5,AX,RF) as change from baseline when inhaling.Baseline and inhaling

R5 - Resistance at 5Hz, R20 - Resistance at 20Hz, X5 - Reactance at 5Hz, RF - Frequency of resonance, AX - Area under reactance curve

Change in cough waves from baseline when inhalingBaseline, Inhaling.

Cough waves will be recorded by a voice recorder.

Trial Locations

Locations (1)

Guangzhou Institute of Respiratory Disease

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath